Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin

Journal of Nutritional Biochemistry

Volumn 22, Issue 5, 2011, Pages 450-458

  Yun, Jung Mi ^a   Jialal, Ishwarlal ^a   Devaraj, Sridevi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylation; Deacetylation; HDAC2 and NF B; P300

Indexed keywords

CURCUMIN; GLUCOSE; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVITY; EPIGENETICS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MONOCYTE;

ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL LINE; CHEMOKINE CCL2; CURCUMIN; CYTOKINES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIGENESIS, GENETIC; GLUCOSE; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; HUMANS; INTERLEUKIN-6; MONOCYTES; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

CURCUMA LONGA;

EID: 79954602833     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.03.014     Document Type: Article

References (57)

1. Brownlee M. Glycation and diabetic complications. Diabetes 1994, 43:826-841.
2. Lyons T. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993, 71:26B-31B.
3. Vlassara H., Bucala R., Sturcker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994, 70:138-151.
4. Guha M., Bai W., Nadler J., Natarajan R. Molecular mechanisms of TNF-alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress dependent and independent pathways. J Biol Chem 2000, 275:17728-17739.
5. Shanmugam N., Reddy M.A., Guha M., Natarajan R. High-glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003, 52:1256-1264.
6. Jain S.K., Kannan K., Lim G., Matthew-Greer J., McVie R., Bocchini J.A. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 2003, 26:2139-2143.
7. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z.Y., Yamauchi T., et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999, 103:185-195.
8. Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol 2007, 99:15-26.
9. Li Y., Reddy M.A., Miao F., Shanmugam N., Yee J.K., Hawkins D., et al. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the Regulation of NF-κB-dependent inflammatory genes: relevance to diabetes and inflammation. J Biol Chem 2008, 283:26771-26781.
10. Miao F., Gonzalo I.G., Lanting L., Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004, 23:18091-18097.
11. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005, 11:191-198.
12. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005, 11:183-190.
13. de Winther M.P., Kanters E., Kraal G., Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005, 25:904-914.
14. Shanmugam N., Kim Y.S., Lanting L., Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Biol Chem 2003, 278:34834-34844.
15. Hayden M.S., Ghosh S. Signaling to NF-κB. Genes Dev 2004, 18:2195-2224.
16. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
17. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260.
18. Chen L.F., Mu Y., Greene W.C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J 2002, 21:6539-6548.
19. Kiernan R., Brès V., Ng R.W., Coudart M.P., El Messaoudi S., Sardet C., et al. Post-activation turn-off NF-κB-dependent transcription is regulated by acetylation of p65. J Biol Chem 2003, 278:2758-2766.
20. Rahman I., Marwick J., Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 2004, 15:1255-1267.
21. Roth S.Y., Denu J.M., Allis C.D. Histone acetyltransferases. Annu Rev Biochem 2001, 70:81-120.
22. Berger S.L. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002, 12:142-148.
23. Marks P.A., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 2001, 1:194-202.
24. Lyon J., La Thangue N.B. Chromatin research gathers pace. Trends Cell Biol 1997, 7:389.
25. Wolffe A.P. Chromatin remodeling: why it is important in cancer. Oncogene 2001, 20:2988-2990.
26. Rouaux C., Jokic N., Mbebi Boutiller S., Leoffler J.P., Boutiller A.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 2003, 22:6537-6549.
27. McKinsey T.A., Olson E.N. Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet 2004, 20:206-213.
28. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res 2004, 32:959-976.
29. Kramer O.H., Gottlicher M., Heinzel T. Histone deacetylase as a therapeutic target. Trends Endocrinol Metab 2001, 12:294-300.
30. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 2007, 26:373S-388S.
31. Rahman I., Biswas S.K., Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 2006, 30:1439-1452.
32. Marcu M.G., Jung Y.J., Lee S., Chung E.J., Lee M.J., Trepel J., et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2006, 2:169-174.
33. Wongcharoen W., Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 2009, 133:145-151.
34. Aggarwal B.B., Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 2004, 1030:434-441.
35. Rahman I., Marwich J., Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and proinflammatory gene expression. Biochem Pharmacol 2004, 15:1255-1267.
36. Ashburner B.P., Westerheide S.D., Baldwin A.S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001, 21:7065-7077.
37. Thompson P.R., Wang D., Wang L., Fulco M., Pediconi N., Zhang D., et al. Regulation of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol 2004, 11:308-315.
38. Ruderman N., Williamson J.R., Brwonlee M. Glucose and diabetic vascular disease. FASEB J 1992, 6:2905-2914.
39. Pugliese G., Tilton R.G., Williamson J.R. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabete Metab Rev 1991, 7:35-59.
40. Jain S.K., Rains J., Croad J., Larson B., Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 2009, 11:241-249.
41. Singh U., Devraj S., Jialal I. Vitamin E, oxidative stress and inflammation. Annu Rev Nutr 2005, 25:151-174.
42. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and oxidative stress. J Clin Invest 2005, 115:1111-1119.
43. Jain S.K., Kannan K., Lim G., McVie R., Bocchini J.A. Hyperketonemia increases TNF-_ secretion in cultured U937 monocytes and type-1 diabetic patients. Diabetes 2002, 51:2287-2293.
44. Nicolls M.R., Haskins K., Flores S.C. Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal 2007, 9:879-889.
45. Pennathur S., Heinecke J.W. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid Redox Signal 2007, 9:955-969.
46. Evans J.L., Maddux B.A., Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005, 7:1040-1052.
47. Devaraj S., Cheung A.T., Jialal I., Griffen S.C., Nguyen D., Glaser N., et al. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 2007, 56:2790-2796.
48. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
49. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000, 404:787-790.
50. Perkins N.D. Post-translational modifications regulating the activity and function of the nuclear factor κB pathway. Oncogene 2006, 25:6717-6730.
51. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998, 1:661-671.
52. Cheung W.L., Briggs S.D., Allis C.D. Acetylation and chromosomal functions. Curr Opin Cell Biol 2000, 12:326-333.
53. Kurdistani S.K., Grunstein M. Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol 2003, 4:276-284.
54. Yeung F. Modulation of NF-κB-dependent transcription and cell survival by the sirt1 deacetylase. EMBO J 2004, 23:2360-2380.
55. El Kharroubi A., Piras R Zensen G., Martin M.A. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol 1998, 18:2535-2544.
56. Ito K., Barnes P., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000, 20:6891-6903.
57. Vanden Berghe W., De Bosscher K., Boone E., Plaisance S., Haegeman G. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 1999, 274:32091-32098.